angiotensin ii has been researched along with Bacterial Pneumonia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guardiola, JJ; Sarmiento, X; Soler, M | 1 |
| Alvarez, C; Castello, L; Geffner, J; Giordano, M; Nahmod, V; Pereyra, Y; Raiden, S | 1 |
1 review(s) available for angiotensin ii and Bacterial Pneumonia
| Article | Year |
|---|---|
[Alcohol and acute respiratory distress syndrome: casuality or causality?].
Topics: Adaptive Immunity; Alcohol-Related Disorders; Alcoholism; Angiotensin II; Animals; Blood-Air Barrier; Causality; Cilia; Comorbidity; Cytokines; Disease Models, Animal; Disease Susceptibility; Humans; Inflammation Mediators; Liver Diseases, Alcoholic; Lung; Oxidative Stress; Phagocytosis; Pneumonia, Bacterial; Pulmonary Surfactants; Respiratory Distress Syndrome; Risk; Sepsis; Water-Electrolyte Imbalance; Wounds and Injuries; Zinc | 2013 |
1 other study(ies) available for angiotensin ii and Bacterial Pneumonia
| Article | Year |
|---|---|
Losartan, a selective inhibitor of subtype AT1 receptors for angiotensin II, inhibits neutrophil recruitment in the lung triggered by fMLP.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cell Movement; Chemotaxis, Leukocyte; Hemorrhage; Losartan; Lung; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2 | 2000 |